ClinicalTrials.gov
ClinicalTrials.gov Menu

Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01174199
Recruitment Status : Terminated (no value in finding efficacy)
First Posted : August 3, 2010
Last Update Posted : September 13, 2016
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Roswell Park Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : August 2015
  Actual Study Completion Date : August 2016